NUTX today

$189.19+$2.94 (+1.58%)close Nov 11, 2026

Trend

DailyDowntrend (starting)

4 hourLeaning Bullish

1 hourExpanding

15 minBearish

5 minConsolidating

Daily trend turns up above $226.16

Key levels

Resistance$215.97

Resistance$198.25

Support$170.00

Support$150.07

About Nutex Health

Nutex Health runs small-scale and specialized medical centers, plus outpatient departments, offering emergency, inpatient, and behavioral care with on-site imaging, labs, and pharmacies. A second division manages networks of independent doctors focused on primary care and population health. It operates in several U.S. states and manages physician groups in multiple metro areas.

Based on the company's 10-K filed Mar 5, 2026.

Nasdaq · Industrials

Nutex Health Inc. (NUTX)

$189.19+2.94 (+1.58%)

WATCHLISTGrade: A+Risk: MEDIUM

1D 5D1M1Y 5Y MaxSign up for all timeframes

High196.69

Low187.00

Open189.90

Volume64K

Avg Vol113K

VWAP190.31

30d High225.00

30d Low179.58

30d Chg-10.89%

See full chart with real-time data

What Is the Price Target for NUTX?

SEPT Low Target

$306.00

SEPT Mid Target

$317.50

SEPT High Target

$336.00

Analyst Consensus

$317.50

Current: $189.19Upside: +67.8%Confidence: 65%Method: Analyst Consensus

Is NUTX a Buy or Sell Right Now?

Investability Score

WATCHLIST12-18 months

News summary · last 30 days

Oct 26▲ UpUpgrade2 articles

Nutex Health (NUTX) shares closed at $208.36, down 2.49% on the day, despite positive analyst news. Ladenburg Thalmann initiated coverage on the stock with a Buy rating and a $336 price target, implying significant upside from current levels. The stock traded in a wide range, hitting a high of $225.00 before pulling back to close at the day's low of $208.36 on volume of 184,753. While the new coverage is a bullish catalyst, the price action suggests near-term selling pressure or profit-taking. The direction signal remains UP based on the analyst initiation and high-impact bullish sentiment.

Critical news

Nov 5HIGHEarnings: growth/beat

Thesis

•Revenue growing 82.4% YoY with ACCELERATING trend — accelerating momentum.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NUTX.

Start Free Trial →

Is NUTX Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/E Forward, P/B, Analyst Consensus

Fair Value

$355.30

Moat Score

NARROW

7/9

Piotroski Score

3.5

Altman Z-Score

What Is Smart Money Doing with NUTX?

Insider Signal

NEUTRAL

3 buys / 1 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Recent Insider Activity

Name	Title	Type	Shares	Value	Date
Saunders Scott J	director	Sale	203	$43K	Sep 18, 2026
Spears Kelvin	director	Buy	2,519	-	Jun 4, 2026
Vo Thomas T.	director officer	Buy	75,747	-	May 28, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

NUTX Growth Story

Revenue YoY

82.4%

3yr Revenue CAGR

58.6%

EPS Growth YoY

8.15%

FCF Growth YoY

N/A%

Revenue Trend

ACCELERATING

Dark Pool Trades for NUTX

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for NUTX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

Time	Price	Size	Value	Side
21:00:47	$189.19	1,022	$$193K	SELL
16:32:20	$195.74	1,000	$$196K	BUY
15:12:17	$189.62	2,036	$$386K	SELL
14:50:25	$188.65	1,100	$$208K	BUY
14:50:25	$188.53	1,000	$$189K	BUY

5 dark pool trades shown · $$1.2M preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Nutex Health Inc. (NUTX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

NUTX — frequently asked questions

What is NUTX stock price today?

Nutex Health Inc. (NUTX) is at $189.19, up 1.58% (+$2.94) at the Nov 11, 2026 close.

Why is NUTX stock moving today?

Latest NUTX news — Nov 9, 2026: Lake Street keeps Buy rating on Nutex Health, lifts target to $333 · Nov 9, 2026: B. Riley Securities keeps Buy rating on Nutex Health, lifts target to $357

Why did NUTX stock move on Oct 26, 2026?

What is the NUTX price target?

The average analyst price target for NUTX is $317.50, ranging from $306 to $336, based on 4 analysts. Latest: Ladenburg Thalmann initiates on Oct 26, 2026.

What do analysts rate NUTX?

Analyst ratings for NUTX: 0 Buy, 7 Hold, 0 Sell — consensus Hold.

Did NUTX beat earnings?

NUTX last reported on Aug 6, 2026: EPS $9.38 vs $4.95 expected — a beat of 89.5%.

What is NUTX's P/E ratio?

NUTX trades at a P/E of 7.9 vs a Industrials average of 25.9.

Does NUTX pay a dividend?

NUTX does not currently pay a dividend.

What are NUTX support and resistance levels?

Support: $170.00, $150.07, $115.81. Resistance: $198.25, $215.97.

What are insiders doing with NUTX?

Insider activity: NEUTRAL, 3 buys and 1 sells in the last 90 days.

What is the latest news on NUTX?

Nov 9, 2026: Lake Street keeps Buy rating on Nutex Health, lifts target to $333 · Nov 9, 2026: B. Riley Securities keeps Buy rating on Nutex Health, lifts target to $357 · Nov 9, 2026: B. Riley Sets $357 Target for Nutex Health